Clinical features, treatment and prognosis of patients with endogenous infectious endophthalmitis-Reference-Cited by-同舟云学术

Clinical features, treatment and prognosis of patients with endogenous infectious endophthalmitis

Published:2024-07-08 Issue:1 Volume:44 Page:
ISSN:1573-2630
Container-title:International Ophthalmology
language:en
Short-container-title:Int Ophthalmol

Author:

Hu Mingjing,Liu Mingzhu,Jin Siyan,Wang Xia,Liu Xiaoli^ORCID

Funder

National Natural Science Foundation of China

Project of Outstanding Talents in Scientific and Technological Innovation and Entrepreneurship for Middle-aged and Young Scientists of Jilin Provincial Science and Technology Department

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10792-024-03208-4.pdf

Reference126 articles.

1. Bhende M, Karpe A, Arunachalam S, Therese KL, Biswas J (2017) Endogenous endophthalmitis due to Roseomonas mucosa presenting as a subretinal abscess. J Ophthalmic Inflamm Infect 7:5. https://doi.org/10.1186/s12348-017-0123-6

2. Regan KA, Radhakrishnan NS, Hammer JD, Wilson BD, Gadkowski LB, Iyer SSR (2020) Endogenous endophthalmitis: yield of the diagnostic evaluation. BMC Ophthalmol 20:138. https://doi.org/10.1186/s12886-020-01418-9

3. Pillai GS, Remadevi KK, Anilkumar V, Radhakrishnan N, Rasheed R, Ravindran GC (2020) Clinical profile and outcome of endogenous endophthalmitis at a quaternary referral centre in south India. Indian J Ophthalmol 68:827–833. https://doi.org/10.4103/ijo.IJO_948_19

4. Cho H, Shin YU, Siegel NH, Yu HG, Sobrin L, Patel A et al (2018) Endogenous endophthalmitis in the American and Korean population: an 8-year retrospective study. Ocul Immunol Inflamm 26:496–503. https://doi.org/10.1080/09273948.2016.1195000

5. Colenbrander A (2002) Preservation of vision or prevention of blindness? Am J Ophthalmol 133:263–265. https://doi.org/10.1016/s0002-9394(01)01314-9